Related Experiment Videos
Galactosylgloboside expression in seminoma. Inverse correlation with metastatic potential
C Ohyama1, S Orikasa, S Kawamura
1Department of Urology, Tohoku University, School of Medicine, Sendai, Japan.
Cancer
|September 15, 1995
Summary
The presence of galactosylgloboside (Gb5) in seminoma tumors correlates with a lower risk of metastasis. Its absence indicates a higher metastatic potential, aiding in prognosis for seminoma patients, particularly in Stage I disease.
Area of Science:
- Oncology
- Biochemistry
- Glycobiology
Background:
- Altered glycosylation is a hallmark of human cancers, closely linked to tumor invasion and metastasis.
- Aberrant glycosylation patterns in seminoma lacked established prognostic information.
- This study investigated the prognostic value of glycosphingolipid (GSL) alterations in seminoma.
Purpose of the Study:
- To analyze the glycosphingolipid (GSL) composition of seminoma tissues.
- To correlate specific GSLs with the metastatic potential of seminoma.
- To evaluate the prognostic utility of GSLs in seminoma patients.
Main Methods:
- Systematic analysis of GSL composition in orchiectomy-derived seminoma samples.
- Comparison of GSL patterns across three patient groups: non-metastatic Stage I, relapsed Stage I, and metastatic Stage II seminoma.
- Chemical characterization of unknown GSLs using 1H-nuclear magnetic resonance spectroscopy and mass spectrometry.
Main Results:
- Non-metastatic seminomas (n=12) consistently showed a GSL band identified as galactosylgloboside (Gb5).
- All metastatic seminomas (n=5) lacked this specific GSL (Gb5).
- Galactosylgloboside (Gb5) was the only GSL that clearly correlated with metastatic potential.
Conclusions:
- The presence or absence of galactosylgloboside (Gb5) is a significant indicator of metastatic potential in seminoma.
- This finding provides a valuable tool for estimating prognosis in seminoma patients.
- Gb5 analysis is particularly useful for assessing risk in Stage I seminoma cases.